Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease

US Patent 11234967 · Granted Feb 1, 2022

Estimated economic value: $2,288,000

Assignee

Inventors

View full patent text on Google Patents →